Supporting clinical relevance of our findings, subsequent experiments were conducted using 3 ng/mL CXCL12, a concentration that is consistent with CXCL12 levels observed in PAH patient plasma [16,17]. Here, CXCL12 is linked to pulmonary arterial hypertension.